Molecular profile
Molecular profile
- Molecule class
- Synthetic peptide
- Origin
- Synthetic fragment
- Primary target system
- Innate-repair-receptor-Komplex aus EPOR und CD131
- Development stage
- Clinical development
Nicht hämatopoetisches Peptidanalogon aus der Helix-B-Oberfläche von Erythropoietin.
Mechanism and signalling
Mechanism and signalling
A heteromeric EPOR–CD131 receptor complex is proposed, potentially affecting resolution of inflammation and tissue protection.
Scientific classification
Scientific classification
This profile maps Cibinetide to the research areas neuro, immune. Molecule class, evidence level, development stage and regulatory status are separated so that preclinical findings are not confused with authorised uses.
Neuropeptides and analogues in models of neuronal signalling, stress and pain.
Innate immunity, epithelial barriers and antimicrobial peptide functions.
Evidence base
Phase II
Phase II studies have investigated neuropathic and inflammatory settings. General medicinal approval has not been granted.
Regulatory status
Investigational substance
The substance remains in clinical development and is not authorised as a generally available medicine. Trial status and regulatory assessment may change.
Safety and use notice
No dosing or administration recommendation
The available evidence does not establish safe self-directed use. This profile intentionally provides no dosing, sourcing or administration guidance.
Sources and registries